Background: Clozapine treatment may have beneficial effects on behavioural outcomes in psychotic disorders, including violent offending. Although clozapine and other antipsychotics have been linked to lower levels of violent behaviour, these have been primarily in small selected samples, and population-based estimates have been limited and imprecise. Methods: This study was a within-person cohort study based on linked prescription, hospitalization, and sociodemographic registers. We assessed the effect of clozapine treatment on the rate of violent and non-violent offending in the whole of Sweden, taking account of time-changing sociodemographic characteristics and the combination of violent and non-violent offences within individual convictions. Results: In a group of people treated with clozapine for psychotic disorders, violent offences were much less common during treatment than before. Effects on non-violent offences were smaller in magnitude, and lost precision on adjustments. There was a trend for the effects of antipsychotic treatment to increase with increasing age at initiation. Smaller but similar effects were observed for olanzapine. Clozapine rate reductions for violent offending were twice as strong for those with a history of alcohol-use disorders, compared to those without, RR for alcohol use disorders. Discussion: In patients with psychotic disorders, clozapine treatment is associated with a lower rate of violent offending compared to olanzapine. Clozapine might reduce offending through a direct effect on psychotic symptoms, or indirectly through changes in lifestyle, including use of alcohol. Background: For patients with refractory schizophrenia, clozapine is the drug of first choice. However, many refractory patients never receive this drug. The underutilization of clozapine may be caused by the labourintensive white blood cell monitoring during the first months and the concerns about the safety of outpatient clozapine initiation. A recent survey concluded that professionals "perceived the presence of dedicated staff to arrange and monitor the initiation of clozapine in outpatients as the factor that would enable the use of clozapine most". We examined whether the presence of such staff in Dutch teams for ambulatory care makes a difference. The primary objective is to examine whether clozapine monitoring by a Nurse Practitioner (NP) is at least as safe as monitoring by a physician. The secondary objective is to examine whether physicians are more likely to prescribe clozapine if they can delegate the monitoring tasks to a NP. Methods: In this cluster-randomized trial, 23 Dutch ambulatory care teams were randomized into 2 conditions: (A) coordination of clozapine monitoring by a Nurse Practitioner, versus (B) Treatment As Usual: coordination of clozapine monitoring by the responsible physician (usually a psychiatrist). We followed the teams for 15 months, during which period we counted the numbers of patients who started with clozapine. We assessed the safety of the clozapine monitoring by measuring the number of weekly lab exams performed during the first 18 weeks of treatment and counting serious adverse events (SAE). It is important to note that the staff of teams remained blind to the secondary research question. Results: Of the 2643 patients with a diagnosis of non-affective psychotic disorder, 66 patients started using clozapine during the follow-up, 48 in condition A and 18 in condition B (RR: 2.14, 95% CI: 1.24-3.70; p=.005). The provisional results showed no significant differences between conditions A and B in the mean number of lab exams performed. In condition A, 65% of the mandatory lab exams were carried out compared to 60% in condition B. No agranulocytosis or other SAE occurred in Conditions A or B. Discussion: Physicians prescribed over 2 times more often clozapine to patients when they could delegate the white blood cell monitoring to a NP. Clozapine-monitoring by an NP appears to be just as safe as monitoring by a physician. These results strongly support the idea that the presence of dedicated staff to arrange and monitor the initiation of clozapine enables the use of this drug.
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